Non‐Invasive Prenatal Testing by Cell‐Free DNA ( cfNIPT ) for Detecting Turner Syndrome With Mosaicism and Structural Variants—Prenatal Findings and Postnatal Outcomes
American Journal of Medical Genetics Part C: Seminars in Medical Genetics · 2025-06 · 199 (2) · 124-133
DOI: 10.1002/ajmg.c.32136 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Medical Genetics Part C: Seminars in Medical Genetics, online erschienen am 05.03.2025. Verfasst von Ivonne Bedei und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Prenatal Diagnosis and Fetal Therapy, Justus-Liebig University, Gießen, Germany. Hauptthemen laut MEDLINE: Turner Syndrome, Mosaicism, Cell-Free Nucleic Acids, Noninvasive Prenatal Testing. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Independent Research Fund Denmark,, Sygesikringen Danmark, Novo Nordisk Fonden.
Abstract (Originalsprache)
Turner Syndrome (TS) is a sex chromosomal disorder associated with karyotype heterogeneity. Although TS can be associated with severe prenatal findings, most often linked to the 45, X karyotype, the majority of TS fetuses have no overt phenotype, resulting in delayed diagnosis and management. The objective of this study is to assess the efficacy of non‐invasive prenatal testing by cell‐free DNA (cfNIPT) in detecting TS fetuses with different TS karyotype variants and to examine the phenotypic variations and clinical outcomes.Data on pregnancies with confirmed or suspected TS from 2000 to 2024 were collected from specialists in fetal ultrasound in Germany. In addition, a small number of Danish cases with 45, X mosaicism in the placenta was included. Data were collected regarding cfNIPT results, karyotypes, prenatal ultrasound findings, and pregnancy outcomes.Of the 114 cases included, 100 (87.7%) had a high‐risk cfNIPT result for monosomy X, 53 (46.5%) were true positives (TP), and 47 (41.2%) were false positives (FP). Fourteen (12.3%) were false negatives (FN). No differences in congenital malformation or nuchal translucency were seen between TP and FN. Data on karyotype were available for 67 cases. Fourty (59.7%) had a 45, X karyotype, 16 (23.9%) 45, X mosaicism, and 11 (16.4%) had a structural variant. The 45, X karyotype was associated with a higher prevalence of congenital malformation and increased nuchal translucency (ps ≤ 0.001). The live birth rate was higher in cases with 45, X mosaicism or structural variants compared to cases with a 45, X karyotype (ps ≤ 0.03). Postnatal phenotypes were often mild.cfNIPT represents a valuable tool for the early identification of fetuses with TS karyotype variants, enabling timely intervention and targeted management. However, the high false‐positive rate underscores the need for careful counseling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Prenatal Diagnosis and Fetal Therapy, Justus-Liebig University, Gießen, Germany.
- Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.
- Department of Clinical Genetics, Aarhus University Hospital, Aarhus, Denmark.
- Department of Biomedicine, Aarhus University, Aarhus, Denmark.
- Department of Clinical Medicine, Center for Fetal Diagnostics, Aarhus University, Aarhus, Denmark.
- Department of Obstetrics and Gynecology, Aarhus University Hospital, Aarhus, Denmark.
ORCID-Profile: Ivonne Bedei, Ida C B Lund, Simon H Thomsen, Ida Vogel, Andrea T Maciel-Guerra, Francisco Alvarez-Nava, Melissa L Crenshaw, Claus H Gravholt, Anne Skakkebæk
Förderung
- the Independent Research Fund Denmark,
- Sygesikringen Danmark
- Novo Nordisk Fonden
Zitieren
APA
Bedei, I., Bruder, J., Lund, I. C. B., Thomsen, S. H., Vogel, I., Maciel-Guerra, A. T., Alvarez-Nava, F., Crenshaw, M. L., Axt-Fliedner, R., Gravholt, C. H., & Skakkebæk, A. (2025). Non‐Invasive Prenatal Testing by Cell‐Free DNA ( cfNIPT ) for Detecting Turner Syndrome With Mosaicism and Structural Variants—Prenatal Findings and Postnatal Outcomes. American Journal of Medical Genetics Part C: Seminars in Medical Genetics, 199(2), 124-133. https://doi.org/10.1002/ajmg.c.32136
Vancouver
Bedei I, Bruder J, Lund ICB, Thomsen SH, Vogel I, Maciel-Guerra AT, et al. Non‐Invasive Prenatal Testing by Cell‐Free DNA ( cfNIPT ) for Detecting Turner Syndrome With Mosaicism and Structural Variants—Prenatal Findings and Postnatal Outcomes. American Journal of Medical Genetics Part C: Seminars in Medical Genetics. 2025;199(2):124-133. doi:10.1002/ajmg.c.32136
BibTeX
@article{Bedei2025,
author = {Bedei, Ivonne and Bruder, Johanna and Lund, Ida C B and Thomsen, Simon H and Vogel, Ida and Maciel-Guerra, Andrea T and Alvarez-Nava, Francisco and Crenshaw, Melissa L and Axt-Fliedner, Roland and Gravholt, Claus H and Skakkebæk, Anne},
title = {Non‐Invasive Prenatal Testing by Cell‐Free DNA ( cfNIPT ) for Detecting Turner Syndrome With Mosaicism and Structural Variants—Prenatal Findings and Postnatal Outcomes},
journal = {American Journal of Medical Genetics Part C: Seminars in Medical Genetics},
year = {2025},
volume = {199},
number = {2},
pages = {124--133},
doi = {10.1002/ajmg.c.32136}
}
EUVIMED